Courtney R. Johnson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Courtney R. Johnson has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Casimir J. Schaefer
Department of Chemistry University of North Carolina at Chapel Hill Chapel Hill North Carolina USA
2 shared publications- Mark H. Schoenfisch
Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
2 shared publications Simon J. Reinhard
Department of Oral Biology College of Dentistry University of Florida Gainesville Florida USA
2 shared publicationsTsian D. Ramrattan
Department of Chemistry University of North Carolina at Chapel Hill Chapel Hill North Carolina USA
2 shared publicationsMadelyn P. Bucci
Department of Oral Biology College of Dentistry University of Florida Gainesville Florida USA
1 shared publicationMikaylin E. Nogler
Department of Chemistry University of North Carolina at Chapel Hill Chapel Hill North Carolina USA
1 shared publication
Latest Publications
- 26 June 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (29) , e71395
Blue Light‐Mediated Nitric Oxide‐Releasing Formulation for the Multimodal Treatment of Acne Vulgaris
The topical treatment of acne vulgaris by a single therapeutic is difficult given the multifaceted causes of the disease. Treatment with photo‐responsive nitric oxide (NO) donors and light represents an attractive alternative to conventional therapeutics due to the potential for multimodal therapeutic action against downstream acne processes. Herein, a topical hyaluronic acid (HA) formulation was developed to facilitate localized NO delivery from mesoporous silica nanoparticle (MSN) NO donors upon blue light exposure, while simultaneously providing anti‐inflammatory activity. The NO release was tunable (0.09–0.51 µmol NO mg −1 ) depending on wavelength, with shorter wavelengths and greater irradiances providing more efficient photolytic liberation. Antibacterial activity and cytocompatibility were directly modulated by photolytic NO release and payload, where NO was determined to be the primary antibacterial agent and large, initial NO bursts led to preservation of cell viability. Incorporation of the MSN‐based NO donors into an HA formulation afforded additional metabolic and immunomodulatory behavior in vitro, demonstrating potential to decrease sebum production and inflammation in acne vulgaris. Blue light‐mediated NO release from the HA formulation presents a multifunctional therapeutic platform that addresses key contributing downstream factors of acne.
- 26 June 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (29) , e71395
Blue Light‐Mediated Nitric Oxide‐Releasing Formulation for the Multimodal Treatment of Acne Vulgaris
The topical treatment of acne vulgaris by a single therapeutic is difficult given the multifaceted causes of the disease. Treatment with photo‐responsive nitric oxide (NO) donors and light represents an attractive alternative to conventional therapeutics due to the potential for multimodal therapeutic action against downstream acne processes. Herein, a topical hyaluronic acid (HA) formulation was developed to facilitate localized NO delivery from mesoporous silica nanoparticle (MSN) NO donors upon blue light exposure, while simultaneously providing anti‐inflammatory activity. The NO release was tunable (0.09–0.51 µmol NO mg −1 ) depending on wavelength, with shorter wavelengths and greater irradiances providing more efficient photolytic liberation. Antibacterial activity and cytocompatibility were directly modulated by photolytic NO release and payload, where NO was determined to be the primary antibacterial agent and large, initial NO bursts led to preservation of cell viability. Incorporation of the MSN‐based NO donors into an HA formulation afforded additional metabolic and immunomodulatory behavior in vitro, demonstrating potential to decrease sebum production and inflammation in acne vulgaris. Blue light‐mediated NO release from the HA formulation presents a multifunctional therapeutic platform that addresses key contributing downstream factors of acne.
- Open Access
- 28 April 2026
- Published by Taylor & Francis in Journal of Oral Microbiology
- Vol. 18 (1)
Treatment of periodontal biofilms via nitric oxide-augmented phototherapy
Periodontal disease is a chronic inflammatory disease of the oral mucosa affecting over 1.1 billion people worldwide with a substantial health care burden [1]. Initiated by subgingival microbiome d...
- 28 April 2026
- Published by Taylor & Francis in Journal of Oral Microbiology
- Vol. 18 (1)
Open AccessTreatment of periodontal biofilms via nitric oxide-augmented phototherapy
Periodontal disease is a chronic inflammatory disease of the oral mucosa affecting over 1.1 billion people worldwide with a substantial health care burden [1]. Initiated by subgingival microbiome d...